2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4364):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-Z0676
    (S)-Ponesimod
    (S)-Ponesimod is a drug impurity.
    (S)-Ponesimod
  • HY-41671
    4-Fluorobenzene-1,3-dicarboxylic acid
    		99.18%
    4-Fluorobenzene-1,3-dicarboxylic acid (NSC 50699) is a drug intermediate for synthesis of various active compounds.
    4-Fluorobenzene-1,3-dicarboxylic acid
  • HY-W025838
    4,5-Dimethylbenzene-1,2-diamine
    		99.93%
    4,5-Dimethylbenzene-1,2-diamine is a substitute for aromatic diamine compound. 4,5-Dimethylbenzene-1,2-diamine act as a bidentate nucleophilic reagent and participates in the palladium (II)-mediated isocyanate addition reaction to construct a diaminocarbene palladium complex with potential catalytic activity.
    4,5-Dimethylbenzene-1,2-diamine
  • HY-50110
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate
    		98.0%
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate is a drug intermediate for synthesis of various active compounds.
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate
  • HY-42109
    Clozapine impurity 8
    		99.29%
    Clozapine impurity 8 is an impurity of Clozapine (HY-14539).
    Clozapine impurity 8
  • HY-47241
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one
    		99.70%
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one is a drug intermediate for synthesis of various active compounds.
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one
  • HY-42593
    (E)-4,6-dichloro-2-styrylpyrimidine
    		98.95%
    (E)-4,6-dichloro-2-styrylpyrimidine is a drug intermediate for synthesis of various active compounds.
    (E)-4,6-dichloro-2-styrylpyrimidine
  • HY-77733
    Ticagrelor impurity 7
    Ticagrelor impurity 7 is an impurity of Ticagrelor (HY-10064).
    Ticagrelor impurity 7
  • HY-I0213
    Quetiapine impurity 25
    		99.98%
    Quetiapine impurity 25 is an impurity of Quetiapine.
    Quetiapine impurity 25
  • HY-40352A
    Tofacitinib impurity 6
    		99.35%
    Tofacitinib impurity 6 is an impurity of Tofacitinib (HY-40354).
    Tofacitinib impurity 6
  • HY-N7033R
    UDP-glucuronic acid trisodium (Standard)
    UDP-glucuronic acid (trisodium) (Standard) is the analytical standard of UDP-glucuronic acid (trisodium). This product is intended for research and analytical applications. UDP-?glucuronic acid trisodium (Uridine-5'-diphosphoglucuronic acid trisodium salt) is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.
    UDP-glucuronic acid trisodium (Standard)
  • HY-Z9072
    Hydrocortisone aceate impurity 2
    Hydrocortisone aceate impurity 2 is an impurity of Hydrocortisone aceate.
    Hydrocortisone aceate impurity 2
  • HY-W128579
    2-Pyrimidinepropanoic acid
    		Control
    2-Pyrimidinepropanoic acid is a synthetic intermediate useful for pharmaceutical synthesis.
    2-Pyrimidinepropanoic acid
  • HY-P3669
    Gly-Gly-Phe-Gly
    		99.97%
    Gly-Gly-Phe-Gly is a peptide spacer and can be applied to Doxorubicin (HY-15142A) (DXR) conjugates. Gly-Gly-Phe-Gly can be used as an ADC linker to synthesize ADCs, such as Puxitatug samrotecan (AZD 8205) (HY-171689).
    Gly-Gly-Phe-Gly
  • HY-185048
    PCB-OAA
    PCB-OAA is a biocompatible multivinyl polycarboxybetaine macromonomer and that exhibits anti-fouling activity. PCB-OAA can form a hydrogel in vitreous cavity and shows an appealing ability to prevent significantly inflammatory response, fibrosis and complications such as raised intraocular pressure, and cataract formation. PCB-OAA can be used for the research of vitreous substitution.
    PCB-OAA
  • HY-138354
    Pyrroline-5-carboxylate
    Pyrroline-5-carboxylate is a key intermediate in proline anabolism and catabolism. Pyrroline-5-carboxylate plays important roles in plant defense against pathogen invasion, as well as in redox regulation, nucleotide synthesis and other processes in animal cells.
    Pyrroline-5-carboxylate
  • HY-59024
    δ-Carboline
    δ-Carboline is a nitrogen-containing heterocyclic compound, and its derivatives all exhibit anti-cancer and antibacterial activities.
    δ-Carboline
  • HY-153402
    Activated EG3 Tail
    		99.31%
    Activated EG3 Tail can be used in the synthesis of exon jumping oligomer conjugates.
    Activated EG3 Tail
  • HY-W048488
    2'-O-MOE-5-Me-rU
    		99.78%
    2'-O-MOE-5-Me-rU is a dual chemically modified ribonucleoside, which is a key modifying unit in the development of RNA drug preparations (such as antisense oligonucleotides ASO, siRNA). Its core function is to significantly enhance the stability, target affinity and drugability of nucleic acid drugs.
    2'-O-MOE-5-Me-rU
  • HY-44087
    Ethyl (E)-3-(1-pyrrolidinyl)crotonate
    		99.73%
    Ethyl (E)-3-(1-pyrrolidinyl)crotonate is an organic synthetic intermediate of the enamine ester type. Ethyl (E)-3-(1-pyrrolidinyl)crotonate has a stable structure and strong reactivity, and is mainly used for the construction of heterocyclic compounds and drug molecules.
    Ethyl (E)-3-(1-pyrrolidinyl)crotonate